Although abnormal myocardial calcium homeostasis in the cardiomyopathic hamster (CMH) has been documented in the hypertrophic stage (Circulation Research 1991;69:123-133) 
). Figure 5A shows the response of DP and EDP to Bay K 8644 in control and CMH hearts. DP was greater in control (in 2.0 mM Cao) than in CMH hearts in agreement with the Ca0 dose-response curve in other hearts (Figure 1 ). In CMH, DP reached maximum and EDP began to increase at lower concentrations of Bay K 8644 than in control hearts. The maximum DP in response to Bay K 8644 was greater in control than in CMH hearts (Table 2 ). Figure SB shows the data in Figure  5A expressed relative to the maximum change of DP in each heart. The curve for CMH hearts is significantly shifted leftward of that of control hearts: the concentration of Bay K 8644 to achieve the halfmaximal response in DP was 0.017±0.002 ,AM in CMH and 0.034+0.004 ,uM in control hearts (n=10 for each; pO.01). In the presence of Bay K 8644, RT1/2 became more prolonged in CMH than in control hearts (Figure 6 ), as was the case when Ca0 was increased (Figure 3) . Relaxation Response to /3-Adrenergic Receptor Stimulation Figure 7 shows the response of DP and EDP to isoproterenol in CMH and control hearts. DP before drug (Ca0=2.0 mM) and maximum DP achieved with
isoproterenol were significantly greater in control than in CMH hearts ( the absence of propranolol) was administered, baseline RT1/2 was greater in CMH than in control hearts, and with isoproterenol it shortened in both control and CMH hearts in a concentration-dependent manner ( Figure 8A ). However, the relative response was attenuated in CMH compared with control hearts ( Figure 8B 7 . The response of developed pressure (DP) and end-diastolic pressure (EDP) to isoproterenol in cardiomyopathic hamster (CMH) and control (C) hearts. The responses ofboth DP and EDP are significantly different between control and CMH hearts (p0.01 and pO0.02 for DP and EDP, respectively, repeated-measures analysis of variance). measured in the absence of electrical stimulation in the presence of isoproterenol because of the spontaneous systoles and extrasystoles that occurred when stimulation was stopped in the absence of propranolol. But, as in the case with Bay K 8644, after cessation of stimulation in the presence of isoproterenol, the gain in cell Ca2+ achieved during stimulation dissipates, and no change in either SLIF or resting pressure would be expected to occur. 25 Response to a-Adrenergic Receptor Stimulation Figure 9A shows the response of DP and EDP to phenylephrine plus 5 ,uM propranolol in control and CMH hearts. The maximum DP achieved with phenylephrine was greater in control than in CMH hearts (Table 2 ). Figure 9B shows the DP data of Figure 9A expressed relative to the maximum change in DP in each heart. The curve of CMH is significantly shifted leftward of that of control hearts: the concentration of phenylephrine required to achieve the half-maximal response in DP was 0.21+0.03 ,uM in CMIH and 0.48±0.08 ,uM in control hearts (n=9 for each; p'0.01). At higher concentrations of phenylephrine, EDP increased in CMI but did not increase in control hearts. RTI/2 increased to a greater extent in CMH than in control hearts ( Figure 10 ). Relaxation time measured from peak pressure to 50% pressure decay was 53.7+2.2 and 59.9±2.7 msec in control and CMH hearts, respectively (p<0.02). In the presence of 10 ,uM phenylephrine, this value was 60.3±2.3 and 70.5±4.5 msec in control and CMH hearts, respectively (p<O.Ol). Figure 11 shows the response of resting pressure and SLIF to phenylephrine. Before application of the drug, resting pressure did not differ between groups; SLIF was undetectable in control but was present in CMH. The phenylephrine responses of both resting pressure and SLIF were significantly steeper in CMH than in control hearts. These responses were completely abolished in the presence of an a-adrenergic receptor antagonist, 1.0 ,uM prazosin (not shown).
Coronary flow did not differ between groups in response to phenylephrine (Table 1) . Discussion The present results show that in isolated hearts from the 24-45-day-old CMH perfused with 1.0 mM Ca0, neither DP, EDP, nor RT1/2 in the presence of propranolol differed from those of control hearts. As Ca0 was increased, DP increased to a lesser and EDP to a greater extent in CMH than in control hearts, and RT1/2 in CMH hearts became prolonged. In a prior study the developed force production of isolated papillary muscles of hypertrophic 120-day-old CMH hearts bathed in 2.4 mM Ca. also exhibited a reduction of developed tension generation and prolonged relaxation. 29 In the present study, not only was the maximum DP achieved in response to an increase in Ca0 less in CMH hearts, but it also occurred at a lower Can; the dose-response curve was shifted leftward. In unstimulated hearts a greater Ca0-dependent rise in EDP and resting pressure occurred in CMH than in control hearts. The Ca0-induced increase in SLIF, a monitor of spontaneous, Phenylephrine (FLM) FIGURE 10 . While multiple specific subcellular mechanisms that govern Ca2+ influx, for example, altered Ca'2 channels, or a-and l3-adrenergic signal transduction pathways might have some role in the observed results, a net decrease in cell Ca2+ buffering capacity or in Ca24 efflux in response to the perturbations used in the present study is also a plausible explanation for the observed results. Possible mechanisms include a reduction in sarcolemmal Ca2+ pump activity, altered Na4-Ca2+ exchange, a reduction in the Na+-K+ pump activity, and a diminution of Ca2+ uptake or enhanced spontaneous efflux by the sarcoplasmic reticulum. Regarding biochemical abnormalities in the sarcolemmal membrane of CMH hearts, it has been reported that while ATP-independent Ca24 binding initially increases at 55 days of age, ATPdependent Ca2+ binding capacity decreases at 90 days of age. Ca2-dependent ATPase decreases only in the late stage of the disease in the CMH, UMX7.1 strain, which is derived from the BIG 14.6 strain.37 However, a reduction of Ca'4-ATPase of cardiac sarcolemma at 40 days of age in the BIO 53.58 strain has been reported in another study.38 Similar interstudy differences have been observed in the case of Na+-Ca'4 exchange. In one study, while no alteration was observed at 40 days of age in CMH hearts, Na+-dependent Ca'4 uptake decreased at 120 and 240 days of age in the UMX7.1 strain versus control hearts.39 More recently it has been observed that Na4-Ca2' exchange in Na+-loaded sarcolemmal vesicles is enhanced at 30 days in the CMH, BIO 14.6 strain. 4 These different results might, in part, be due to the strain studied, for example, due to the different severity of disease between strains. No change in Ca24 sequestration by isolated sarcoplasmic reticulum occurs in the early phase of the disease. 15 However, during later stages of the disease, that is, at 9 months of age, the initial rate and capacity of Ca24 uptake by the sarcoplasmic reticulum and Ca'2-ATPase activities from the sarcoplasmic reticulum vesicles become significantly decreased.15 Regarding Na+,K+-ATPase activity, while the cytosolic Na4 concentration has not been measured in CMH hearts during the prenecrotic stage, a reduced Na+,K+-ATPase activity under certain experimental conditions has been observed as early as 25 days in UMX7.1 in the CMH strain.37 However in the BIO 53.58 strain no significant changes in Na+,K+-ATPase activity were detected at 40 days of age. 38 In summary, based on the current literature, specific abnormalities in none of the cell surface or intracellular biochemical mechanisms that regulate the cell ionic homeostasis can be firmly linked to the abnormalities of Ca'4 homeostasis demonstrated in the prehypertrophic CMH hearts investigated in the present study. Thus, additional and more focused measurements of mechanisms of ionic control are required in this regard.
Regardless of the specific cellular mechanism involved, the tendency for young CMH hearts to become Ca'2 overloaded in response to a Ca2+ stress, as observed in the present study, need not be homogeneous among myocardial cells and could progressively increase with age. This could eventually lead to a focal Ca2+ necrosis observed at later stages in the disease.1-620 Additionally, an abnormal Ca2+ loading by vascular smooth muscle cells in vivo, leading to spasm after ischemia and reperfusion,16-'8could also contribute to altered myocyte cell Ca'2 handling and be implicated in focal necrosis at later stages of the disease. However, the present results, in providing evidence for a myocardial cell component, suggest that the Ca'2 overload of the cardiomyopathy that later develops is not solely vascular in origin. 
